# Xbiotech (XBIT) — Overview

XBIT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/xbit

## Price

Last close $2.17 on Oct 15, 2026. 52-week range $2.12 – $2.94.

## Company profile

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $0.00 |
| Revenue (quarter) | $0.00 |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $0.00 |
| Gross margin | 0.00% |
| Net income (trailing twelve months) | $0.00 |
| Net income (quarter) | −$6.7M |
| Net income growth (year over year) | -283.14% |
| Net margin | 0.00% |
| Return on equity | -29.94% |
| EPS (trailing twelve months) | −$1.48 |
| Book value per share | $4.21 |
| P/E (trailing twelve months) | — |
| Price to book | 0.5 |
| Debt to assets | 3.88% |
| Payout ratio | -431.03% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### How do I buy stock in Xbiotech (XBIT)?

XBIT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).